Eton Pharmaceuticals, Inc. ($ETON)
Erdogan-Trinkaus Ipek โ Chief Commercial Officer
Shares
3,500
Price
$0.00
Total Value
$0.00
Nearby Earnings
Nov 5, 2026
EPS:Est: 0.31
Revenue:Est: $41.98M
Transaction Details
| Insider | Erdogan-Trinkaus Ipek |
|---|---|
| Title | Chief Commercial Officer |
| Transaction Date | Nov 10, 2026 |
| Exercise Date | Jan 12, 2026 |
| Expiration Date | Jan 11, 2030 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Employee Stock Option |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Nov 12, 2026 |
| Shares Purchased | 3,500 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 37,155 |
| Derivative | Derivative |
| Accession Number | 0001437749-26-036605 |
| Document | View SEC Filing |